Genotype analysis based on intergenic spacer 1 sequences of Trichosporon asahii collected in Taiwan

References

• Chen YC, Chang SC, Tai HM, Hsueh PR, Luh KT. Molecular epidemiology of Candida colonizing critically ill patients in intensive care units. J Formos Med Assoc 2001; 100: 791–797.
   PubMed Web of Science ®Google Scholar
• Li SY, Yang YL, Chen KW, et al. Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients. Epidemiol Infect 2006; 134: 265–269.
   Google Scholar
• Miranda LN, van der Heijden IM, Costa SF, et al. Candida colonisation as a source for candidaemia. J Hosp Infect 2009; 72: 9–16.
   PubMed Web of Science ®Google Scholar
• Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol 1994; 32: 975–980.
   PubMed Web of Science ®Google Scholar
• Colombo AL, Padovan AC, Chaves GM. Current knowledge of Trichosporon spp. and trichosporonosis. Clin Microbiol Rev 2011; 24: 682–700.
   PubMed Web of Science ®Google Scholar
• Warnock DW. Trends in the epidemiology of invasive fungal infections. Nippon Ishinkin Gakkai Zasshi 2007; 48: 1–12.
   PubMedGoogle Scholar
• Yang YL, Cheng MF, Wang CW, et al. The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan. Med Mycol 2010; 48: 328–334.
   PubMed Web of Science ®Google Scholar
• Yang YL, Ho YA, Cheng HH, Ho M, Lo HJ. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol 2004; 25: 60–64.
   PubMed Web of Science ®Google Scholar
• Yang YL, Li SY, Cheng HH, Lo HJ. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002. Diagn Microbiol Infect Dis 2005; 51: 179–183.
   PubMed Web of Science ®Google Scholar
• Yang YL, Wang AH, Wang CW, et al. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2006. Diagn Microbiol Infect Dis 2008; 61: 175–180.
   PubMedGoogle Scholar
• Chagas-Neto TC, Chaves GM, Melo AS, Colombo AL. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol 2009; 47: 1074–1081.
   PubMed Web of Science ®Google Scholar
• Hajjeh RA, Blumberg HM. Bloodstream infection due to Trichosporon beigelii in a burn patient: case report and review of therapy. Clin Infect Dis 1995; 20: 913–916.
   Google Scholar
• Tashiro T, Nagai H, Kamberi P, et al. Disseminated Trichosporon beigelii infection in patients with malignant diseases: immunohistochemical study and review. Eur J Clin Microbiol Infect Dis 1994; 13: 218–224.
   PubMedGoogle Scholar
• Walsh TJ. Trichosporonosis. Infect Dis Clin North Am 1989; 3: 43–52.
   PubMedGoogle Scholar
• Leaw SN, Chang HC, Barton R, Bouchara JP, Chang TC. Identification of medically important Candida and non-Candida yeast species by an oligonucleotide array. J Clin Microbiol 2007; 45: 2220–2229.
   PubMedGoogle Scholar
• Leaw SN, Chang HC, Sun HF, et al. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol 2006; 44: 693–699.
   PubMed Web of Science ®Google Scholar
• Diaz MR, Boekhout T, Theelen B, Fell JW. Molecular sequence analyses of the intergenic spacer (IGS) associated with rDNA of the two varieties of the pathogenic yeast, Cryptococcus neoformans. Syst Appl Microbiol 2000; 23: 535–545.
   PubMed Web of Science ®Google Scholar
• Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 2002; 40: 1826–1830.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, et al. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 2005; 49: 4026–4034.
   PubMed Web of Science ®Google Scholar
• Clinical Laboratory Standard Instiute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, approved standard, M27-A3. 3rd ed. Wayne, PA: Clinical Laboratory Standards Institute; 2008.
   Google Scholar
• Guo LN, Xiao M, Kong F, et al. Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China. J Clin Microbiol 2011; 49: 3805–3811.
   PubMed Web of Science ®Google Scholar
• Kalkanci A, Sugita T, Arikan S, et al. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients. Med Mycol 2010; 48: 141–146.
   PubMed Web of Science ®Google Scholar
• Mekha N, Sugita T, Ikeda R, et al. Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients. Mycopathologia 2010; 169: 67–70.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Tudela JL, Gomez-Lopez A, Alastruey-Izquierdo A, et al. Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn Microbiol Infect Dis 2007; 58: 435–440.
   Google Scholar
• Sun W, Su J, Xu S, Yan D. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. J Med Microbiol 2012; 61: 1750–1757.
   PubMed Web of Science ®Google Scholar
• Xia Z, Yang R, Wang W, Cong L. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients. Mycopathologia 2012; 173: 127–133.
   Google Scholar
• Sugita T, Ikeda R, Nishikawa A. Analysis of Trichosporon isolates obtained from the houses of patients with summer-type hypersensitivity pneumonitis. J Clin Microbiol 2004; 42: 5467–5471.
   PubMed Web of Science ®Google Scholar
• Tsai MS, Yang YL, Wang AH, et al. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates. Mycopathologia 2012; 174: 121–130.
   Google Scholar
• Araujo Ribeiro M, Alastruey-Izquierdo A, Gomez-Lopez A, Rodriguez-Tudela JL, Cuenca-Estrella M. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital. Rev Iberoam Micol 2008; 25: 221–225.
   Google Scholar
• Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, et al. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother 2002; 46: 1144–1146.
   PubMed Web of Science ®Google Scholar
• Ruan SY, Hsueh PR. Invasive candidiasis: an overview from Taiwan. J Formos Med Assoc 2009; 108: 443–451.
   PubMed Web of Science ®Google Scholar